FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3145688766> ?p ?o ?g. }

• W3145688766 abstract "Abstract Background PIK3CA is the second most frequently mutated gene in cancers and is extensively studied for its role in promoting cancer cell resistance to chemotherapy or targeted therapy. However, PIK3CA functions have mostly been investigated at a lower-order genetic level, and therapeutic strategies targeting PIK3CA mutations have limited effects. Here, we explore crucial factors interacting with PIK3CA mutations to facilitate a significant marginal survival effect at the higher-order level and identify therapeutic strategies based on these marginal factors. Methods Mutations in stomach adenocarcinoma (STAD), breast adenocarcinoma (BRCA), and colon adenocarcinoma (COAD) samples from The Cancer Genome Atlas (TCGA) database were top-selected and combined for Cox proportional-hazards model analysis to calculate hazard ratios of mutation combinations according to overall survival data and define criteria to acquire mutation combinations with considerable marginal effects. We next analyzed the PIK3CA + HMCN1 + LRP1B mutation combination with marginal effects in STAD patients by Kaplan-Meier, transcriptomic differential, and KEGG integrated pathway enrichment analyses. Lastly, we adopted a connectivity map (CMap) to find potentially useful drugs specifically targeting LRP1B mutation in STAD patients. Results Factors interacting with PIK3CA mutations in a higher-order manner significantly influenced patient cohort survival curves (hazard ratio (HR) = 2.93, p-value = 2.63 × 10 − 6 ). Moreover, PIK3CA mutations interacting with higher-order combination elements distinctly differentiated survival curves, with or without a marginal factor (HR = 0.26, p-value = 6.18 × 10 − 8 ). Approximately 3238 PIK3CA- specific higher-order mutational combinations producing marginal survival effects were obtained. In STAD patients, PIK3CA + HMCN1 mutation yielded a substantial beneficial survival effect by interacting with LRP1B (HR = 3.78 × 10 − 8 , p-value = 0.0361) and AHNAK2 (HR = 3.86 × 10 − 8 , p-value = 0.0493) mutations. We next identified 208 differentially expressed genes (DEGs) induced by PIK3CA + HMCN1 compared with LRP1B mutation and mapped them to specific KEGG modules. Finally, small-molecule drugs such as geldanamycin (connectivity score = − 0.4011) and vemurafenib (connectivity score = − 0.4488) were selected as optimal therapeutic agents for targeting the STAD subtype with LRP1B mutation. Conclusions Overall, PIK3CA -induced marginal survival effects need to be analyzed. We established a framework to systematically identify crucial factors responsible for marginal survival effects, analyzed mechanisms underlying marginal effects, and identified related drugs." @default.
• W3145688766 created "2021-04-13" @default.
• W3145688766 creator A5022154995 @default.
• W3145688766 creator A5030338991 @default.
• W3145688766 creator A5055276001 @default.
• W3145688766 creator A5062170722 @default.
• W3145688766 date "2021-04-07" @default.
• W3145688766 modified "2023-09-28" @default.
• W3145688766 title "Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer" @default.
• W3145688766 cites W1502914454 @default.
• W3145688766 cites W1513665108 @default.
• W3145688766 cites W1522256851 @default.
• W3145688766 cites W1815168662 @default.
• W3145688766 cites W1933096416 @default.
• W3145688766 cites W1981406217 @default.
• W3145688766 cites W1992477322 @default.
• W3145688766 cites W2034514162 @default.
• W3145688766 cites W2035258932 @default.
• W3145688766 cites W2036836102 @default.
• W3145688766 cites W2041483726 @default.
• W3145688766 cites W2043652702 @default.
• W3145688766 cites W2054966870 @default.
• W3145688766 cites W2102014488 @default.
• W3145688766 cites W2114031931 @default.
• W3145688766 cites W2117263216 @default.
• W3145688766 cites W2121232254 @default.
• W3145688766 cites W2128542677 @default.
• W3145688766 cites W2133054306 @default.
• W3145688766 cites W2139306838 @default.
• W3145688766 cites W2143497970 @default.
• W3145688766 cites W2159933536 @default.
• W3145688766 cites W2237359059 @default.
• W3145688766 cites W2460053185 @default.
• W3145688766 cites W2510227974 @default.
• W3145688766 cites W2519654776 @default.
• W3145688766 cites W2544310790 @default.
• W3145688766 cites W2582417961 @default.
• W3145688766 cites W2612467560 @default.
• W3145688766 cites W2744377419 @default.
• W3145688766 cites W2766316939 @default.
• W3145688766 cites W2767814595 @default.
• W3145688766 cites W2889851758 @default.
• W3145688766 cites W2896872272 @default.
• W3145688766 cites W2898408701 @default.
• W3145688766 cites W2900814520 @default.
• W3145688766 cites W2911655697 @default.
• W3145688766 cites W2912656088 @default.
• W3145688766 cites W2920683253 @default.
• W3145688766 cites W2984955289 @default.
• W3145688766 cites W2998018162 @default.
• W3145688766 cites W3081664850 @default.
• W3145688766 doi "https://doi.org/10.1186/s12885-021-08115-w" @default.
• W3145688766 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8028071" @default.
• W3145688766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33827485" @default.
• W3145688766 hasPublicationYear "2021" @default.
• W3145688766 type Work @default.
• W3145688766 sameAs 3145688766 @default.
• W3145688766 citedByCount "5" @default.
• W3145688766 countsByYear W31456887662021 @default.
• W3145688766 countsByYear W31456887662022 @default.
• W3145688766 countsByYear W31456887662023 @default.
• W3145688766 crossrefType "journal-article" @default.
• W3145688766 hasAuthorship W3145688766A5022154995 @default.
• W3145688766 hasAuthorship W3145688766A5030338991 @default.
• W3145688766 hasAuthorship W3145688766A5055276001 @default.
• W3145688766 hasAuthorship W3145688766A5062170722 @default.
• W3145688766 hasBestOaLocation W31456887661 @default.
• W3145688766 hasConcept C104317684 @default.
• W3145688766 hasConcept C121608353 @default.
• W3145688766 hasConcept C126322002 @default.
• W3145688766 hasConcept C143998085 @default.
• W3145688766 hasConcept C150194340 @default.
• W3145688766 hasConcept C152724338 @default.
• W3145688766 hasConcept C162317418 @default.
• W3145688766 hasConcept C207103383 @default.
• W3145688766 hasConcept C2780140570 @default.
• W3145688766 hasConcept C2781182431 @default.
• W3145688766 hasConcept C44249647 @default.
• W3145688766 hasConcept C501734568 @default.
• W3145688766 hasConcept C502942594 @default.
• W3145688766 hasConcept C50382708 @default.
• W3145688766 hasConcept C54355233 @default.
• W3145688766 hasConcept C71924100 @default.
• W3145688766 hasConcept C86803240 @default.
• W3145688766 hasConceptScore W3145688766C104317684 @default.
• W3145688766 hasConceptScore W3145688766C121608353 @default.
• W3145688766 hasConceptScore W3145688766C126322002 @default.
• W3145688766 hasConceptScore W3145688766C143998085 @default.
• W3145688766 hasConceptScore W3145688766C150194340 @default.
• W3145688766 hasConceptScore W3145688766C152724338 @default.
• W3145688766 hasConceptScore W3145688766C162317418 @default.
• W3145688766 hasConceptScore W3145688766C207103383 @default.
• W3145688766 hasConceptScore W3145688766C2780140570 @default.
• W3145688766 hasConceptScore W3145688766C2781182431 @default.
• W3145688766 hasConceptScore W3145688766C44249647 @default.
• W3145688766 hasConceptScore W3145688766C501734568 @default.
• W3145688766 hasConceptScore W3145688766C502942594 @default.
• W3145688766 hasConceptScore W3145688766C50382708 @default.
• W3145688766 hasConceptScore W3145688766C54355233 @default.
• W3145688766 hasConceptScore W3145688766C71924100 @default.

• next